
Now loading...
Axis Securities recommends an overweight call on Lupin with a target price of Rs 2600. Lupin’s current price is Rs 2160. New launches in the US are expected to boost sales. Recent approvals have potential for additional revenue. The company plans to improve its margins and expand its India business with increased Medical Representative numbers.
Now loading...